Evidence map›Paper›PMID 28393050›Full record

ReviewFrontiers in cellular and infection microbiology2017

How Do the Virulence Factors of

Emily Mattock, Ariel J Blocker

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 134 papers.

0numbers the graph read from it
0cells of the map it votes in
134citing papers in PubMed
15.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

134 citing papers in PubMed, 258 citations in OpenAlex.

  1. Trial
  2. Antibodies Elicited by theFrontiers in immunology · 2021
    Trial
  3. New microbes and new infections · 2026
    Review
  4. bioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Shigellosis.Lancet (London, England) · 2025
    Review
  15. Article
  16. Article
  17. Repurposing of Furin Inhibitors to Reduce PathogenicAntibiotics (Basel, Switzerland) · 2025
    Article
  18. Modulation of Macrophages TLR4-Mediated Transcriptional Response byInternational journal of molecular sciences · 2025
    Article
  19. Article
  20. Review

74 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Emily MattockFaculty of Biomedical Sciences, Schools of Cellular and Molecular Medicine and Biochemistry, University of Bristol Bristol, UK.
Ariel J BlockerFaculty of Biomedical Sciences, Schools of Cellular and Molecular Medicine and Biochemistry, University of Bristol Bristol, UK.
University of Bristol · GB

Funding

Wellcome TrustWellcome Trust WT104634AIA
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adaptive ImmunityAnimalsBacterial AdhesionDysentery, BacillaryEpitheliumHost-Pathogen InteractionsHumansImmunity, InnateImmunomodulationIntestinal MucosaPlasmidsShigellaType III Secretion SystemsVirulenceVirulence FactorsType III Secretion SystemsVirulence Factorsbacterial pathogenesisShigellaShigellosistype III secretion systemvirulence effectors

Identifiers

PMID28393050
PMCPMC5364150
OpenAlexW2602209783

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.